Search results
Zepbound: Weight Loss Drugs Can Help Reduce Sleep Apnea Symptoms
Healthline· 1 day agoThe obesity and diabetes medication tirzepatide (Mounjaro, Zepbound) reduced obstructive sleep apnea...
Can Weight Loss Drugs Like Wegovy and Zepbound Help You Live a Longer Life?
Healthline via AOL· 4 days agoCardiovascular disease “Obesity increases one’s risk of all aspects of cardiovascular diseases...
Bariatric Surgery Lowers CV Risk in People With Sleep Apnea
Medscape· 19 hours agoThis study is important "because it targets the main driver" of OSA, which is obesity and fat accumulation, Ali Aminian, MD, of the Cleveland Clinic, told Medscape Medical ...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal via Yahoo Finance· 6 days agoThe FDA is expected to decide on whether to approve the drug by the end of the year. Life expectancies around the world have surged in recent...One might...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day ago/GLP-1 RA), which is marketed as Mounjaro for type II diabetes and Zepbound for obesity. The GLP-1...
3 Biotech Stocks to Buy Now: June 2024
InvestorPlace· 1 day agoRecently, the biotech industry has taken a bit of a slower stance toward growth. With the Covid-19 pandemic in the rearview mirror, the focus of major...
Gateway - Quartz
Quartz· 5 days agoThe world’s largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties “created a high risk of consumer confusion and deception as well as potential ...
Palatin initiates Bremelanotide-PDE5i Phase II trial for ED
Clinical Trials Arena via Yahoo Finance· 2 days agoLast week, Palatin started a Phase II clinical trial of breatelanotide, a melanocortin 4 receptor...
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool via Yahoo Finance· 5 days agoThe catch is that Structure is still toward the beginning of its life as a biotech. It hasn't yet...
Eli Lilly Issues Warning About Fake Weight-Loss Drugs
KPVI· 2 days agoOn June 20, Eli Lilly published an open letter, warning about fake and compounded versions of...
